Liberty One Investment Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13
| Closed | -$2.37K | – | 169 |
|
2024
Q3 | $2.37K | Sell |
13
-127
| -91% | -$23.1K | ﹤0.01% | 168 |
|
2024
Q2 | $26K | Sell |
140
-19
| -12% | -$3.53K | ﹤0.01% | 157 |
|
2024
Q1 | $28.3K | Buy |
159
+8
| +5% | +$1.42K | ﹤0.01% | 156 |
|
2023
Q4 | $18.7K | Buy |
151
+52
| +53% | +$6.45K | ﹤0.01% | 142 |
|
2023
Q3 | $11.5K | Buy |
99
+10
| +11% | +$1.16K | ﹤0.01% | 135 |
|
2023
Q2 | $10.4K | Hold |
89
| – | – | ﹤0.01% | 141 |
|
2023
Q1 | $7.13K | Buy |
+89
| New | +$7.13K | ﹤0.01% | 161 |
|
2021
Q4 | – | Sell |
-2,697
| Closed | -$141K | – | 146 |
|
2021
Q3 | $141K | Sell |
2,697
-72
| -3% | -$3.76K | 0.02% | 134 |
|
2021
Q2 | $188K | Buy |
2,769
+667
| +32% | +$45.3K | 0.03% | 134 |
|
2021
Q1 | $162K | Buy |
2,102
+545
| +35% | +$42K | 0.03% | 131 |
|
2020
Q4 | $93K | Buy |
1,557
+520
| +50% | +$31.1K | 0.02% | 129 |
|
2020
Q3 | $45K | Buy |
1,037
+527
| +103% | +$22.9K | 0.01% | 133 |
|
2020
Q2 | $21K | Buy |
+510
| New | +$21K | ﹤0.01% | 134 |
|